Navigating FDA Guidelines and NY State Regulations on Cryopreserved Male Reproductive Tissue
This article discusses the complexities of cryopreservation of reproductive tissues for fertility preservation and donor conception, particularly focusing on regulatory compliance. It outlines the distinctions between donor categories, eligibility requirements, and infectious disease testing mandated by the FDA and New York State, emphasizing safety protocols to reduce the risk of disease transmission.